News Conference News TCT 2016 Sentinel Cerebral Protection Device in TAVR ‘Promising’ but Trial Misses Primary Endpoint Shelley Wood November 01, 2016
News Daily News FDA Approves Amplatzer PFO Occluder for Prevention of Recurrent Stroke Yael L. Maxwell October 28, 2016
News Conference News PCR London Valves 2016 Cerebral Protection in TAVR: New Insights, New Questions as First Device Seeks FDA Clearance Shelley Wood September 22, 2016
News Daily News Stroke Risk With TAVR: In-Depth Review of PARTNER and CoreValve Data Reveals Opportunities and Unknowns Shelley Wood September 13, 2016
News Daily News FDA Expands Indications for Two Endovascular Stroke Therapies Todd Neale September 06, 2016
Presentation TVT 2016 TVT 1039: Transcatheter Aortic Valve Replacement With Evolut-R CoreValve to Simultaneously Treat Severe Calcific Aortic Stenosis and a Large Aortic Root Pseudo-aneurysm in a High-risk Patient Presenter: Nirat Beohar June 17, 2016
News Conference News EuroPCR 2016 Embolic Protection in TAVR: If, When, What, and How Debated as Trials Wrap Up Shelley Wood May 20, 2016
Presentation EuroPCR 2016 A Patient Level Pooled Analysis of NeuroProtection with the TriGuard Embolic DEFLECTion Device Compared to Unprotected Transcatheter Aortic Valve Replacement Presenter: Alexandra Lansky May 20, 2016
News Daily News ¿Predilatación o No Predilatación en TAVR? Una Serie Europea Tranquiliza en Ambos Sentidos Michael O'Riordan May 02, 2016
News Daily News Predilatation or No Predilatation in TAVR? European Series Offers Reassurances Both Ways Michael O'Riordan May 02, 2016
Presentation Usefulness of Predilatation Prior to Transcatheter Aortic Valve Replacement Presenter: Matteo Pagnesi April 29, 2016
News Daily News Bajan los Índices de ACV y Aumentan las Dudas sobre los Dispositivos de Protección Embólica en las Intervenciones TAVR Michael O'Riordan March 14, 2016
News Daily News As Stroke Rates Fall, Questions Mount for Embolic Protection Devices in TAVR Michael O'Riordan March 14, 2016
News Daily News Un Grupo asegura que la TAVR Transcarotídea es Viable y Podría Reemplazar Otras Alternativas al Abordaje Transfemoral Shelley Wood March 07, 2016
News Daily News Transcarotid TAVR Is Feasible, Could Supplant Other Alternatives to Transfemoral, Group Says Shelley Wood March 07, 2016
News Conference News TCT 2015 Low 1-Year Event Rates Seen After TAVR With Sapien 3 Todd Neale October 15, 2015